13F filing recap · Q2 2025
What did Engaged Capital buy in Q2 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$357.62M
Positions
7
Estimated turnover
41.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Engaged Capital opened a new position in Freshpet and exited Chart Industries, NCR Voyix, and NCR Atleos. It substantially increased its stake in Yeti Holdings and added to Evolent Health, while trimming Portillo’s and slightly reducing V.F. Corporation and GXO Logistics.